Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myoadenylate deaminase deficiency.

H H Goebel, A Bardosi, B Conrad

    Klinische Wochenschrift
    |April 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Achievement of Target Gain Larger than Unity in an Inertial Fusion Experiment.

    Physical review letters·2024
    Same author

    Lawson Criterion for Ignition Exceeded in an Inertial Fusion Experiment.

    Physical review letters·2022
    Same author

    Rare case of remission of a patient with small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) stage IV: Case report.

    International journal of surgery case reports·2020
    Same author

    PACAP deficiency as a model of aging.

    GeroScience·2018
    Same author

    Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient mice.

    Reproduction (Cambridge, England)·2017
    Same author

    German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Primary myoadenylate deaminase deficiency is a distinct metabolic muscle disease causing weakness and cramps. Diagnosis requires assessing ammonia levels, muscle enzyme activity, and biopsy findings.

    Area of Science:

    • Biochemistry
    • Muscle Physiology
    • Metabolic Myopathies

    Background:

    • Muscle weakness and exercise intolerance are common symptoms with diverse etiologies.
    • Metabolic myopathies represent a group of genetic disorders affecting muscle energy production.
    • Myoadenylate deaminase (AMPD) is an enzyme crucial for purine metabolism in skeletal muscle.

    Observation:

    • Two unrelated males presented with distinct muscle complaints: one with sarcoidosis/myopathy and weakness, the other with exercise-induced weakness and myalgia.
    • Both patients exhibited an absence of serum ammonia increase post-ischemic work testing.
    • Repeated muscle biopsies revealed minimal histochemical AMPD activity and <5% of normal biochemical activity in skeletal muscles.

    Findings:

    • The consistent lack of ammonia rise, low histochemical activity, and severely reduced biochemical activity of AMPD in muscle biopsies establish primary myoadenylate deaminase deficiency.

    Related Experiment Videos

  • This deficiency presents as a primary metabolic myopathy.
  • These findings differentiate it from other causes of muscle weakness.

    • Implications:

    • Primary myoadenylate deaminase deficiency should be considered in the differential diagnosis of unexplained muscle weakness and cramps.
    • Accurate diagnosis allows for targeted management and counseling.
    • Further research into AMPD deficiency pathophysiology and therapeutic strategies is warranted.